Pharmacologic interactions with new drugs
e-ESO Podcasts - Un pódcast de ESO - European School of Oncology
Categorías:
Expert: Anastasios Stathis, Oncology Institute of Southern Switzerland, Bellinzona, CH Questions: 1-How drug-drug interactions can be defined? 2-How frequent they are? 3-Can you make some examples with new drugs approved for lymphoid malignancies? 4-Do all new drugs have the same risk of interactions? 5-What is the best management?
